Cell-free nucleic acids as biomarkers in cancer patientsHeidi Schwarzenbach, Dave S.�B. Hoon(Saint John's Health Center), Klaus Pantel(University Medical Center Hamburg-Eppendorf)Nature reviews. CancerMay 12, 201110.1038/nrc3066Cited by 2,879SaveCiteExport RISWatch citationsAbstractRelated PapersThe first 30 years of p53: growing ever more complexArnold J. Levine, Moshe Oren|Nature reviews. Cancer|2009|2kSynergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancerElizabeth E. Cameron, Kurtis E. Bachman, Sanna Myöhänen et al.|Nature Genetics|1999|1.9kQuantification of Plasma Epstein–Barr Virus DNA in Patients with Advanced Nasopharyngeal CarcinomaJin‐Ching Lin, Wenyi Wang, Kuang Yu Chen et al.|New England Journal of Medicine|2004|921Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung CancerZhibin Hu, Xi Chen, Yang Zhao et al.|Journal of Clinical Oncology|2010|801Phase I/II study of GSK2118436, a selective inhibitor of oncogenic mutant BRAF kinase, in patients with metastatic melanoma and other solid tumors.Richard Kefford, Hendrik‐Tobias Arkenau, Michael P. Brown et al.|Journal of Clinical Oncology|2010|274